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after nephrectomy was 40 and 70%, respectively, in obese pa-Influence of obesity on the appearance of proteinuria and renal
tients at nephrectomy. At 20 years after nephrectomy, theseinsufficiency after unilateral nephrectomy.
percentages were 8 and 35%, respectively. In contrast, in non-Background. Some patients develop proteinuria and pro-
obese patients, the probability of negative proteinuria and nor-gressive renal failure after unilateral nephrectomy, although
mal renal function was 93 and 98%, respectively, at 10 yearsthe majority of patients maintain normal renal function. Rea-
(P , 0.001) and 77 and 91%, respectively, at 20 years (P ,sons to explain this different evolution are not known.
0.001). Multiple logistic regression analysis showed that theMethods. A cross-sectional study was performed in 73 pa-
risk of developing renal disease was only statistically correlatedtients who had undergone unilateral nephrectomy 13.6 6 8.6
with BMI at the time of unilateral nephrectomy (odds ratioyears before. Patients with morphologic abnormalities in the
1.34, 1.03 to 1.76 CI).remaining kidney, systemic disorders, or abnormal renal func-
Conclusions. Obese patients are at risk for developing pro-tion at the time of nephrectomy were excluded. All of the 73
teinuria and chronic renal failure after unilateral nephrectomy.included patients showed normal renal function and negative
Regular and long-term follow-up are recommended in theseproteinuria at nephrectomy. The patient’s medical records
patients.were reviewed, and clinical and analytical data throughout
follow-up were obtained.
Results. Fifty-three out of the 73 patients (group I) showed
a normal renal function and negative proteinuria at the cross-
Laboratory studies in animals have shown that asectional study. The remaining 20 patients (group II) showed
marked reduction in renal mass leads to structural andproteinuria (3.4 6 3.1 g/day). The time elapsed between ne-
phrectomy and proteinuria appearance was 10.1 6 6.1 years. functional changes in the remaining nephrons [1, 2]. Pro-
Thirteen patients of group II had developed renal insufficiency gressive sclerosis of glomeruli, clinically expressed by
(serum creatinine at the cross-sectional study of 3.9 1 3.2 mg/ proteinuria, hypertension, and azotemia, is the final re-
dL) in addition to proteinuria. The time elapsed between pro-
sult of these maladaptive mechanisms [3, 4]. A clinicalteinuria appearance and the onset of renal insufficiency was
counterpart of this process, known as glomerular hyper-4.1 6 4.3 years. Renal insufficiency showed a slowly progressive
course in most of these patients. There were no significant filtration or hyperfiltration nephropathy, has been re-
differences between group I and group II patients in age, gen- ported in humans with extensive renal mass reductions
der, renal function, or blood pressure at the time of nephrec- [5, 6]. However, the long-term consequences of the re-
tomy. In contrast, group II patients showed a body mass index
moval of one kidney remain controversial. Several stud-(BMI) that was significantly higher than group I at nephrec-
ies have failed to demonstrate progressive renal deterio-tomy (31.6 6 5.6 vs. 24.3 6 3.7 kg/m2, P , 0.001), at cross-
sectional study (33.3 6 6.6 vs. 25.1 6 3.5 kg/m2, P , 0.001), ration in living kidney donors, although some patients
and throughout follow-up. Among the 14 obese (BMI . 30 develop proteinuria and hypertension [7–10]. On the
kg/m2) patients at the time of nephrectomy, 13 (92%) devel- other hand, the long-term follow-up of patients that un-oped proteinuria/renal insufficiency. In contrast, among the 59
derwent unilateral nephrectomy for reasons other thanpatients with BMI , 30 kg/m2, only 7 (12%) developed these
kidney donation has yielded contradictory results; whereascomplications (P , 0.001). Kaplan–Meier estimated probabil-
ity of negative proteinuria and normal renal function 10 years many patients maintain a normal renal function over the
years, several studies have shown that a considerable
number of cases develop proteinuria and progressive
Key words: renal mass reduction, hyperfiltration nephropathy, protein-
renal failure very suggestive of hyperfiltration nephropa-uria, chronic renal insufficiency, angiotensin converting enzyme inhibi-
tors. thy [10–16].
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segmental glomerulosclerosis with hypertrophied glo- and the following data at the time of nephrectomy were
meruli is the most commonly found histologic lesion [17]. obtained: age, blood pressure, BW, body mass index
In addition to clinical conditions that cause a reduction (BMI), SCr, CCr, and proteinuria. The patients had been
in the number of functioning nephrons (surgical ablation, re-examined periodically in our outpatient clinic and the
oligomeganephronia, unilateral agenesis, reflux neph- same data were obtained from their medical records at
ropathy), a clinical picture that is very suggestive of hyp- every review. A complete blood count, routine serum
erfiltration nephropathy has been reported in conditions biochemistry (including glucose, creatinine, uric acid,
with an initially normal nephron population, such as calcium, phosphorus, sodium, potassium, cholesterol,
obesity, cyanotic heart diseases, or sickle cell anemia tryglicerides, total proteins, albumin, bilirubin, alkaline
[17–22]. In the present study, we evaluated renal function phosphatase, aspartate aminotransferase, alanine amino-
in patients with unilateral nephrectomy in order to ana- transferase, and lactate dehydrogenase), urine sediment
lyze those factors involved in the appearance of protein- examination, and 24-hour proteinuria and CCr were ob-
uria and chronic renal failure. tained at every visit.
Blood pressure was measured with a standard mercury
sphygmomanometer. Systolic and diastolic blood pres-METHODS
sures were measured after five minutes of rest in a sitting
The study subjects were identified among patients at-
position; the average of two measurements was recorded.tending our outpatient clinic in the period from June
Mean arterial pressure (MAP) was calculated as the dia-1997 to June 1998 who had undergone unilateral ne-
stolic blood pressure plus one third of the pulse pressure.phrectomy at least 12 months before study. The following
BMI was calculated as the weight in kilograms dividedcriteria for eligibility were established: absence of mor-
by the square of the height in meters. Obesity was definedphologic abnormalities in the remaining unilateral kid-
as a BMI higher than 30 kg/m2; overweight was consid-ney, such as nephrolithiasis, hydronephrosis, parenchy-
ered as a BMI between 27 and 29.9 kg/m2 [23]. Renal insuf-mal scars, or masses; a follow-up period after nephrec-
ficiency was defined as a SCr higher than 1.4 mg/dL to-tomy of longer than one year; a normal urinalysis at
gether with a CCr lower than 70 mL/min/1.73 m2. The slopethe time of nephrectomy, with negative proteinuria and
of the reciprocal of SCr plotted versus time was calculatednormal values of serum creatinine (SCr) or blood urea
in every patient throughout the follow-up and also beforenitrogen; and the absence of any postoperative disorder
and after initiation of angiotensin-converting enzymethat might affect renal function, such as multisystem
(ACE) inhibition. A renal biopsy had been performed indiseases, diabetes mellitus, chronic liver diseases, or
two patients before the study. Renal biopsy specimenschronic infectious diseases.
(light microscopy, electron microscopy, and immunofluo-From 115 patients who had undergone unilateral ne-
rescence) were reviewed for this study. The mean di-phrectomy, 73 met all of the eligibility criteria for entry
ameter of normal, nonsclerosed glomeruli was calculatedinto the study. Among the remaining 42 patients, the
in both renal biopsies. Standard autoanalyzer methodsreasons for exclusion were as follows: In 14 patients, data
were used for measurement of biochemical parameters.of renal function and results of urinalysis at the time of
Urinary albumin excretion was measured by radioimmu-nephrectomy could not be obtained. Ten patients were
noassay. Microalbuminuria was defined as a urinary al-excluded because of the presence of morphologic abnor-
bumin excretion rate of between 30 and 300 mg/day.malities in the remaining kidney (chronic pyelonephritis
with scars in 4, renal calculi in 3, and obstructive uropathy
Statistical analysisin 3). Five patients had type II diabetes mellitus, and
The values are expressed as mean 6 SD. For statisticalfour others a liver cirrhosis; finally, the period of follow-
analysis, we used paired and unpaired Students’ t-test whenup had been shorter than one year in nine patients.
appropriate. The chi-square test was used for qualitativeThe following cross-sectional study was performed in
variables. Slopes of reciprocal of SCr were calculated us-the 73 included patients: medical history and physical
ing linear regression analysis. The study of data evolutionexamination including blood pressure measurement;
throughout the follow-up was performed with the analy-body weight (BW) and height were recorded in every
sis of variance for repeated measurements (ANOVA).case. SCr and measurement of 24-hour creatinine clear-
The maintenance of negative proteinuria and normalance (CCr), 24-hour proteinuria, and microalbuminuria
renal function was estimated by survival analysis ac-were performed three times during a two-month period,
cording to the Kaplan–Meier method, and log-rank testand the three measurements were averaged. Other tests
was used for comparison of different groups. Stepwiseincluded a complete blood count, routine serum bio-
multiple logistic regression analysis was performed tochemistry profile, urine sediment examination, and urine
determine the influence of different parameters at theculture. An abdominal echography was performed in ev-
ery case. The patient’s medical records were reviewed, time of nephrectomy on development of proteinuria and
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Table 1. Clinical characteristics of patients at the time of unilateral nephrectomy
Patients who Patients who later
maintained normal developed proteinuria/
Total renal function renal insufficiency
(N573) (Group I) (N553) P value (Group II) (N520)
Age years 39.7614.7 39614 NS 41614
(11–66) (11–65) (11–66)
Gender 35 M; 38 F 24 M; 29 F NS 11 M; 9 F
Mean arterial pressure 94612 93612 NS 98612
mm Hg (70–140) (70–140) (80–130)
Serum creatinine 160.1 0.960.1 NS 160.1
mg/dL (0.7–1.4) (0.7–1.3) (0.9–1.4)
Proteinuria g/24 hours 0 0 NS 0
Body weight kg 68612 63.568.9 ,0.001 80.1612.1
(40–99) (40–85) (53–99)
Body mass index kg/m2 26.265.3 24.363.7 ,0.001 31.665.6
(18–41.4) (18–34) (22–41.4)
renal insufficiency. P values , 0.05 were considered sta- patients; it reached nephrotic range (higher than 3.5
tistically significant. g/day) in 12 patients (60%). However, none of them
developed hypoalbuminemia, hypoproteinemia, or ne-
phrotic edema in spite of proteinuria values higher thanRESULTS
10 g/day in some cases.
Clinical characteristics of the 73 patients included in Thirteen out of the 20 patients with proteinuria also
the study are expressed in Table 1. Reasons for nephrec- showed renal insufficiency at the cross-sectional study
tomy were nephrolithiasis in 29 patients, renal masses (Table 2). Proteinuria always preceded the appearance
in 14, pyelonephritic atrophy in 14, unilateral hydrone- of renal insufficiency. No patient developed renal func-
phrosis in 11, and renal tuberculosis in 5. Mean follow- tion worsening in the first five years after nephrectomy.
up after unilateral nephrectomy was 13.6 6 8.6 years, The time elapsed between proteinuria appearance and
ranging from 18 months to 35 years. the onset of renal insufficiency (SCr .1.4 mg/dL and CCr
,70 mL/min/1.73 m2) was 4.1 6 4.3 years, ranging fromPatients with normal renal function (group I)
1 to 12 years. Mean SCr of group II patients at the momentFifty-three out of the 73 included patients showed a
of cross-sectional study (Table 2) was 3.9 6 3.2 mg/dL
normal renal function together with normal urine sedi-
(1.1 to 10.6), and CCr was 46.2 6 33.8 mL/min/1.73 m2 (6ment and negative proteinuria in the cross sectional
to 103). Renal insufficiency showed a slowly progressivestudy, performed 11.3 6 7.5 (1.5 to 34.5) years after
course in most of group II patients (Fig. 2). Fifteen pa-unilateral nephrectomy (Table 2). Urinary albumin ex-
tients (75%) showed arterial hypertension during thecretion was also within normal limits (0 to 30 mg/24
follow-up. In addition to salt restriction and several anti-hours). The revision of medical records confirmed the
hypertensive drugs (diuretics, b blockers, and calciumnormality of urinalysis and renal function throughout the
channel antagonists), 11 patients were treated with ACEfollow-up period. Hypertension (blood pressure higher
inhibitors trying to halt the progression of renal insuffi-than 140/90 mm Hg) had been detected in 14 (26%) of
ciency. The mean SCr at the onset of this treatment wasthese patients in the last 10 years before study.
1.9 6 0.9 mg/dL (1 to 4.1 mg/dL); there were no changes
in the rate of renal failure progression after the introduc-Patients with proteinuria/renal insufficiency (group II)
tion of ACE inhibitors, as reflected by the slope of theThe remaining 20 patients, in contrast, showed clear
reciprocal of SCr: 20.0363 6 0.0459 dL/mg/month pre-abnormalities of renal function (Table 2). Proteinuria
treatment versus 20.0331 6 0.0330 dL/mg/month post-was detected in all of them in the cross sectional study,
treatment (P 5 NS).ranging from 0.6 to 13 g/day. The revision of medical
A renal biopsy had been performed in two group IIrecords showed that the time elapsed between nephrec-
patients, both of them with nephrotic-range proteinuriatomy and proteinuria appearance was 10.1 6 6.1 years,
(3.9 and 3.7 g/day) and normal renal function 9 andranging from 3 to 21 years. In most of the group II
14 years after nephrectomy. The revision of specimenspatients (14 out of 20), proteinuria appeared within the
showed lesions of focal segmental glomerulosclerosis infirst 15 years of follow-up, but in two cases, it was de-
15 and 20% of glomeruli and global sclerosis in 18 andtected more than 20 years after nephrectomy (Fig. 1).
Proteinuria showed a slowly progressive increase in most 27%, respectively; severe interstitial fibrosis and tubular
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Table 2. Comparison of patients with normal renal function (group I) or with proteinuria/renal insufficiency (group II)
at the cross sectional study
Group I (N553) P value Group II (N520)
Follow-up after nephrectomy 11.367.5 ,0.001 19.668.6
years (1.5–34.5) (7–35)
Follow-up with negative proteinuria 11.367.5 NS 10.166.1
years (1.5–34.5) (3–21)
Mean arterial pressure 95611 ,0.05 10269
mm Hg (71–123) (86–123)
Serum creatinine mg/dL 0.960.1 ,0.001 3.963.2
(0.7–1.3) (1.1–10.6)
Proteinuria g/24 hours 0 ,0.001 3.463.1
(0.5–13)
Body weight kg 6669.1 ,0.001 84.4614.2
(46–89) (50–106)
Body mass index kg/m2 25.163.5 ,0.001 33.366.6
(19–32.3) (22.2644.1)
Serum total proteins g/dL 7.360.5 NS 7.160.5
(6.6–8.9) (6.3–8.5)
Serum albumin g/dL 4.760.3 NS 4.560.3
(4.2–5.5) (4–5.2)
Serum cholesterol mg/dL 219641 NS 214649
(135–296) (129–320)
Serum triglycerides mg/dL 97627 ,0.01 1696105
(52–141) (49–385)
Fig. 1. Number of patients who developed
proteinuria at each time interval. The cumula-
tive number of patients with proteinuria is
represented by the continuous line.
atrophy were observed. Glomerular diameter was en- nificantly higher in group II patients (Table 2); however,
at the time of nephrectomy, there was no significantlarged (272 6 35 and 265 6 24 mm, respectively).
difference between the two groups (Table 1). ANOVA
Comparison between patients with normal renal analysis of MAP values throughout follow-up showed
function (group I) and proteinuria/renal that MAP was significantly higher in group II patients
insufficiency (group II) (101 6 10 vs. 94 6 11 mm Hg in group I, P , 0.001).
However, the comparison of MAP values at each follow-There were no significant differences in gender or in
the age at the time of nephrectomy (Table 1). Reasons up time interval showed that this significant difference
was observed only beyond the 15th year of follow-upfor unilateral nephrectomy in group II patients who later
developed proteinuria/renal insufficiency were urolithi- (group I, 93 6 6 mm Hg vs. group II, 102 6 10 mm Hg,
P , 0.001), when most of group II patients had devel-asis in seven patients, atrophic pyelonephritis in four,
renal masses in four, unilateral hydronephrosis in three, oped renal insufficiency. A comparison of MAP values
at earlier time intervals did not show significant differ-and renal tuberculosis in two, without significant differ-
ences with group I patients. ences (0 to 5 years of follow-up, group I, 97 6 11 mm Hg
vs. group II, 102 6 10 mm Hg; 6 to 10 years of follow-At the time of the cross-sectional study, MAP was sig-
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Fig. 2. Evolution of serum creatinine (SCr) in group I (r, solid line) Fig. 3. Probability of negative proteinuria in obese (dashed line) and
and group II (j, dashed line) (*P , 0.05). nonobese (solid line) patients (log-rank test, P , 0.001).
up, 95 6 13 vs. 102 6 10 mm Hg; 11 to 15 years of
follow-up, 97 6 10 vs. 101 6 9 mm Hg). There were no
differences in the type of antihypertensive drugs admin-
istered to hypertensive patients in both groups. During
the first 15 years of follow-up, the percentage of patients
treated with ACE inhibitors was similar: 7% in group I
and 10% in group II. Beyond this period, the percentage
of group II patients treated with ACE inhibitors was
higher (75 vs. 9% in group I) in an attempt to halt the
progression of renal failure in proteinuric patients. SCr
and CCr were within normal limits at the time of nephrec-
tomy in all of the 73 included patients, without significant
differences between groups.
Fig. 4. Probability of normal renal function in obese (dashed line) andStriking significant differences in BW and BMI were
nonobese (solid line) patients (log-rank test, P , 0.001).
found between both groups. Patients of group II that
developed proteinuria/renal insufficiency showed BW
and BMI significantly higher than group I patients, who
maintained a normal renal function with negative pro- nephrectomy; during follow-up, their weights increased
teinuria throughout follow-up; these differences were above 30 kg/m2. Therefore, at the time of the cross-
evident at the time of nephrectomy [BW 80.1 6 12.1 sectional study, 16 (80%) out of 20 group II patients
(range 53 to 99) versus 63.5 6 8.9 (40 to 85) kg, P , with proteinuria/renal insufficiency were obese; two oth-
0.001, and BMI 31.6 6 5.6 (22 to 41.4) vs. 24.3 6 3.7 (18 ers were overweight (BMI 27.2 and 27.9 kg/m2), and only
to 34) kg/m2, P , 0.001], at the time of the cross-sectional two patients (10%) had a BMI ,27 (22.2 and 22.9 kg/m2).
study [BW 84.4 6 14.2 (50 to 106) vs. 66 6 9.1 (46 to As it is shown in Figures 3 and 4, the probability of
89) kg, P , 0.001, and BMI 33.3 6 6.6 (22.2 to 44.1) vs. negative proteinuria and normal renal function through-
25.1 6 3.5 (19 to 32.3) kg/m2, P , 0.001], and throughout out the follow-up after nephrectomy was significantly
the follow-up [BW 85.5 6 13.6 (50 to 112) vs. 65.1 6 8.5 lower in obese patients: 10 years after nephrectomy, they
(46 to 89), P , 0.001, and BMI 33.7 6 6 (22 to 44.2) were 40 and 70%, respectively, in obese patients and 93
vs. 24.9 6 3.1 (19 to 32.5), P , 0.001]. At the time of and 98%, respectively, in nonobese patients (P , 0.001).
nephrectomy, 14 patients (19%) were obese. Fifteen Twenty years after nephrectomy, these probabilities
were overweight (20%), and 44 (60%) showed a normal were 8 and 35% in obese patients and 77 and 91% in
BMI. Among the 14 obese patients at the time of ne- nonobese patients (P , 0.001).
phrectomy, 13 (92%) developed proteinuria/renal insuf- The mean follow-up was significantly longer in group
II patients: 19.6 6 8.6 (7 to 35) years versus 11.3 6 7.5ficiency. In contrast, among the 59 nonobese patients,
only 7 (11%) developed these complications (P , 0.001). (1.5 to 34.5) years, P , 0.001. Nevertheless, there were
no significant differences between the follow-up of groupFurthermore, three of these latter seven patients had a
BMI between 27 and 30 (overweight) at the time of I and the follow-up of group II until the appearance of
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Table 3. Variables at the time of nephrectomy influencing the development of proteinuria/renal insufficiency
Univariate analysis Multivariate analysis
Variable P value P value Odds ratio 95% CI
Body mass index ,0.001 0.032 1.34 1.03–1.76
Body weight ,0.001 NS
Length of follow-up ,0.05 NS
Age NS NS
Gender NS NS
Mean arterial pressure NS NS
Serum creatinine NS NS
Creatinine clearance NS NS
proteinuria: 11.3 6 7.5 (1.5 to 34.5) versus 10.1 6 6.1 (3 tive proteinuria (group I). Almost all (90%) group II
patients were obese or were overweight at the time ofto 21) years. Moreover, among group I patients, there
nephrectomy or during the follow-up. Multivariate anal-were 17 cases with a follow-up longer than 15 years who
ysis confirmed that BMI at nephrectomy was the onlydid not develop proteinuria nor renal function worsen-
significant risk factor for the ultimate development ofing, and in whom microalbuminuria remained negative
nephropathy (Figs. 3 and 4).or within normal values at the cross-sectional study. Clin-
Extensive (5/6) renal ablation in rats has been the mostical characteristics of these 17 patients of group I, regard-
commonly studied model of renal failure progressioning age, gender, blood pressure, and SCr at the time of
in the last 20 years [1–4]. Hemodynamic maladaptivenephrectomy, were very similar to that of group II pa-
mechanisms, glomerular hypertrophy in the remnanttients. Again, the only significant differences were found
nephrons, and increased synthesis of vasoactive and fi-in BW and BMI, which were significantly higher in group
brogenic substances [such as angiotensin II, endothelin,II [BW 80.1 6 12.1 (53 to 99) kg vs. 60.3 6 8 (44 to 78) kg,
transforming growth factor-b1 (TGF-b1)] lead to pro-P , 0.001; BMI 31.6 6 5.6 (22 to 41.4) kg/m2 vs. 23.6 6
gressive glomerulosclerosis, interstitial fibrosis, and azo-3.1 (18 to 31) kg/m2, P , 0.001].
temia [24–27]. Despite an impressive number of experi-Significant correlations between BMI at the time of
mental studies in this field, the question of whether thesecross sectional study and proteinuria (r 5 0.40, P ,
findings also occurred in humans with reduced renal mass0.001), SCr (r 5 0.35, P , 0.001), and CCr (r 5 20.35, P ,
remains a matter of discussion. Very prolonged follow-0.001) were found. There was a significant correlation
up of living kidney donors has shown that maintenancebetween BMI at nephrectomy and the rate of renal fail-
of normal renal function is the rule [7–10], although aure progression, estimated by the slope of the reciprocal
variable proportion develops mild proteinuria and hy-of SCr (r 5 20.43, P , 0.01). Multiple logistic regression
pertension [28–30]. On the other hand, a clinical pictureanalysis showed that the risk of developing proteinuria/
resembling the hyperfiltration nephropathy of experi-renal insufficiency after unilateral nephrectomy was sta-
mental studies (proteinuria, hypertension, and progres-tistically correlated with BMI at the time of nephrectomy
sive renal insufficiency with glomerular and interstitial(Table 3). Other variables that showed a statistical corre-
sclerosis) has been described in the few patients sufferinglation on univariate analysis (such as BW and length of
partial removal of a solitary kidney [5, 6, 31]. Clinicalfollow-up) failed to show this significance on multivariate
information about the long-term consequences of unilat-analysis.
eral nephrectomy is contradictory; some studies have
reported that a considerable number of patients develop
DISCUSSION proteinuria and progressive renal failure [14–16]. Strik-
In this study, we have found that obesity is a significant ingly, the measurement of BW or BMI is not recorded in
risk factor for the appearance of progressive renal failure published clinical studies about the evolution of patients
after unilateral nephrectomy. Twenty patients (group II) with renal mass reduction.
with normal renal function and no evidence of gross Several lines of evidence support a connection be-
abnormalities in the remaining kidney on ultrasound ex- tween obesity and clinical conditions related to glomeru-
amination showed a slowly progressive proteinuria and lar hyperfiltration: Obese subjects show increased glo-
derangement of renal function in the absence of any merular filtration rates [32–34], and the glomerular
other identifiable cause of renal disease. Their BMIs, volume of the obese is significantly higher than that of
both at nephrectomy and throughout the follow-up, were subjects with normal BMI [20–22]. Proteinuria is a recog-
significantly higher than that of the remaining 53 patients nized complication of massive obesity, and some cases
develop progressive renal insufficiency [21, 22]; histo-who had maintained a normal renal function and nega-
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logic findings in these cases (focal and segmental glomer- Taking into account the strong association between obe-
sity and the risk to develop renal complications afterulosclerosis, hypertrophied glomeruli, tubulointerstitial
fibrosis) have also been suggestive of hyperfiltration dis- unilateral nephrectomy shown by our study, avoidance
of weight gain or weight loss in obese patients shouldorders.
The pathogenic mechanisms through which obesity be repeatedly recommended to patients with reduced
renal mass, even before the appearance of proteinuria.induces proteinuria are unknown. The common presence
of insulin resistance and hyperinsulinemia among obese Similarly, ACE inhibitors or angiotensin receptor antag-
onists that have demonstrated a beneficial effect on thesubjects could play a pathogenic role through the preglo-
merular vasodilation induced by insulin [32–34]. Lipid course of chronic proteinuric nephropathies [41, 42]
could halt the progression toward renal failure whenabnormalities and hypertension, also frequently associ-
ated with obesity, could collaborate in the progressive started in the early phases of renal damage.
Our study shows that 20 out of 73 patients (27%)renal damage [35]. Obese patients show leptin levels
higher than normal, and serum leptin levels correlate developed proteinuria/renal insufficiency after unilateral
nephrectomy. These data suggest that the developmentstrongly with BMI [36]. Interestingly, recent studies have
shown that leptin stimulates proliferation of glomerular of hyperfiltration nephropathy with serious clinical con-
sequences is not uncommon after surgical renal massendothelial cells, increasing the expression of glomerular
TGF-b and the deposition of type IV collagen [37]; in reduction. However, the retrospective character of our
study does not allow an estimation of the true incidencethese experimental studies, the intraperitoneal adminis-
tration of leptin induced proteinuria and glomeruloscle- of such a complication, as many patients undergoing
uneventful unilateral nephrectomies are not followed uprosis. These studies suggest that leptin could play an
important role in the pathogenesis of glomerulosclerosis after surgery. On the other hand, it is likely that other
unknown pathogenic factors, in addition to obesity, playassociated with obesity. Considering that a very similar
pathogenic sequence (increased expression of TGF-b, a role in the development of renal complications after
unilateral nephrectomy. Thus, in our study, some obeseincreased synthesis of extracellular matrix proteins, pro-
teinuria, and glomerulosclerosis) is observed in experi- patients did not develop proteinuria or renal insuffi-
ciency on the long-term follow-up after nephrectomy,mental animals after renal mass reduction, we suggest
that the coexistence of obesity and a reduced number whereas other patients who showed these complications
were not obese. It is known that the nephron number inof functioning nephrons should be considered as a high
risk condition for the development of proteinuria and otherwise healthy humans can oscillate between 300,000
and more than 1,200,000 per kidney [39]; it is conceivablerenal failure.
It should be stressed that, at variance with experimen- that patients with a low number of nephrons per kidney
would be more susceptible to the development of hyper-tal models, the appearance of clinical consequences after
renal mass reduction is a very slow process in humans. filtration nephropathy after the removal of one kidney.
Our findings could also be applicable to human renalOur group II patients are good examples of this state-
ment because proteinuria and renal insufficiency ap- transplantation, a clinical condition characterized by re-
duced renal mass and the common presence of obesitypeared after many years of postnephrectomy follow-up.
Another clinical characteristic of group II patients was [43]. In conclusion, our study shows that obese patients
are at risk of developing proteinuria and chronic renalthe absence of edema and hypoalbuminemia despite
massive protein losses observed in some cases. In previ- failure after the performance of unilateral nephrectomy.
Regular follow-ups with periodic determinations of bloodous studies, we have shown that this peculiarity is charac-
teristic of hyperfiltration nephropathies; it is possible pressure, proteinuria, and renal function are strongly
recommended for these patients.that the very slow appearance of proteinuria observed
in these disorders allows compensatory mechanisms to
Reprint requests to Manuel Praga, M.D., Servicio de Nefrologi´a,
counterbalance protein losses [38]. In addition, renal Hospital 12 de Octubre, Carretera de Andaluci´a Km 5,400, 28041 Ma-
drid, Spain.biopsies performed in two group II patients showed the
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